Diclofenac Disrupts the Circadian Clock and through Complex Cross-Talks Aggravates Immune-Mediated Liver Injury—A Repeated Dose Study in Minipigs for 28 Days
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24021445 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Saravanakumar Selvaraj und 3 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Pharmacology and Toxicology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany. Hauptthemen laut MEDLINE: Circadian Clocks. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 188 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Federal Ministry of Education and Research (BMBF), Prospective European Drug-Induced Liver Injury Network, Division of Toxicology, Korea Institute of Toxicology (KIT).
Abstract (Originalsprache)
Diclofenac effectively reduces pain and inflammation; however, its use is associated with hepato- and nephrotoxicity. To delineate mechanisms of injury, we investigated a clinically relevant (3 mg/kg) and high-dose (15 mg/kg) in minipigs for 4 weeks. Initially, serum biochemistries and blood-smears indicated an inflammatory response but returned to normal after 4 weeks of treatment. Notwithstanding, histopathology revealed drug-induced hepatitis, marked glycogen depletion, necrosis and steatosis. Strikingly, the genomic study revealed diclofenac to desynchronize the liver clock with manifest inductions of its components CLOCK, NPAS2 and BMAL1. The > 4-fold induced CRY1 expression underscored an activated core-loop, and the dose dependent > 60% reduction in PER2mRNA repressed the negative feedback loop; however, it exacerbated hepatotoxicity. Bioinformatics enabled the construction of gene-regulatory networks, and we linked the disruption of the liver-clock to impaired glycogenesis, lipid metabolism and the control of immune responses, as shown by the 3-, 6- and 8-fold induced expression of pro-inflammatory CXCL2, lysozyme and ß-defensin. Additionally, diclofenac treatment caused adrenocortical hypertrophy and thymic atrophy, and we evidenced induced glucocorticoid receptor (GR) activity by immunohistochemistry. Given that REV-ERB connects the circadian clock with hepatic GR, its > 80% repression alleviated immune responses as manifested by repressed expressions of CXCL9(90%), CCL8(60%) and RSAD2(70%). Together, we propose a circuitry, whereby diclofenac desynchronizes the liver clock in the control of the hepatic metabolism and immune response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Pharmacology and Toxicology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.
- Department of Predictive Toxicology, Korea Institute of Toxicology, Daejeon 34114, Republic of Korea.
ORCID-Profile: Jürgen Borlak
Förderung
- German Federal Ministry of Education and Research (BMBF)
- Prospective European Drug-Induced Liver Injury Network
- Division of Toxicology, Korea Institute of Toxicology (KIT)
- Ministry of Science, ICT and Future Planning
Zitieren
APA
Selvaraj, S., Oh, J. H., Yoon, S., & Borlak, J. (2023). Diclofenac Disrupts the Circadian Clock and through Complex Cross-Talks Aggravates Immune-Mediated Liver Injury—A Repeated Dose Study in Minipigs for 28 Days. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24021445
Vancouver
Selvaraj S, Oh JH, Yoon S, Borlak J. Diclofenac Disrupts the Circadian Clock and through Complex Cross-Talks Aggravates Immune-Mediated Liver Injury—A Repeated Dose Study in Minipigs for 28 Days. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24021445
BibTeX
@article{Selvaraj2023,
author = {Selvaraj, Saravanakumar and Oh, Jung-Hwa and Yoon, Seokjoo and Borlak, Jürgen},
title = {Diclofenac Disrupts the Circadian Clock and through Complex Cross-Talks Aggravates Immune-Mediated Liver Injury—A Repeated Dose Study in Minipigs for 28 Days},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24021445}
}
EUVIMED